Published in J Neurochem on October 01, 1994
Proteasome inhibitors: an expanding army attacking a unique target. Chem Biol (2012) 2.26
Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity. J Cell Biol (2003) 1.77
Involvement of the molecular chaperone Ydj1 in the ubiquitin-dependent degradation of short-lived and abnormal proteins in Saccharomyces cerevisiae. Mol Cell Biol (1996) 1.69
Role of proteasomes in disease. BMC Biochem (2007) 1.65
Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB. Mol Cell Biol (1999) 1.54
Aging perturbs 26S proteasome assembly in Drosophila melanogaster. FASEB J (2007) 1.49
Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. EMBO J (1996) 1.48
Heat-shock protein 90 and Cdc37 interact with LKB1 and regulate its stability. Biochem J (2003) 1.37
Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B. Proc Natl Acad Sci U S A (1996) 1.32
PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. FASEB J (2009) 1.29
Differential regulation of NF-kappaB2(p100) processing and control by amino-terminal sequences. Mol Cell Biol (1996) 1.21
Induced expression of trimerized intracellular domains of the human tumor necrosis factor (TNF) p55 receptor elicits TNF effects. J Cell Biol (1997) 1.03
Initiation of cyclin B degradation by the 26S proteasome upon egg activation. J Cell Biol (1997) 0.90
Lactacystin requires reactive oxygen species and Bax redistribution to induce mitochondria-mediated cell death. Br J Pharmacol (2009) 0.87
The activation sequence of cellular protein handling systems after proteasomal inhibition in dopaminergic cells. Chem Biol Interact (2013) 0.82
Proteasome inhibition leads to early loss of synaptic proteins in neuronal culture. J Neural Transm (Vienna) (2012) 0.78
Peptide and Peptide-Like Modulators of 20S Proteasome Enzymatic Activity in Cancer Cells. Int J Pept Res Ther (2006) 0.77
Development of two novel high-throughput assays to quantify ubiquitylated proteins in cell lysates: application to screening of new anti-malarials. Malar J (2015) 0.77
Y-632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo. Cancer Sci (2016) 0.76
Purification and Recognition of Recombinant Mouse P2X(1) Receptors Expressed in a Baculovirus System. Drug Dev Res (2000) 0.76
Ischemic tolerance in an in vivo model of glutamate preconditioning. J Neurosci Res (2014) 0.75
Proteasome as a Molecular Target of Microcystin-LR. Toxins (Basel) (2015) 0.75
Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J (1995) 5.24
A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J (1994) 4.04
Evidence that pituitary cation-sensitive neutral endopeptidase is a multicatalytic protease complex. J Neurochem (1983) 2.18
Cerebrospinal fluid levels of MHPG in affective disorders. Nature (1972) 1.78
Cation-sensitive neutral endopeptidase: isolation and specificity of the bovine pituitary enzyme. J Neurochem (1980) 1.74
Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat Med (1998) 1.69
Prolyl endopeptidase. Life Sci (1983) 1.54
Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex. Arch Biochem Biophys (2000) 1.53
Membrane bound pituitary metalloendopeptidase: apparent identity to enkephalinase. Biochem Biophys Res Commun (1981) 1.47
Design and development of a mobile system for supporting emergency triage. Methods Inf Med (2005) 1.47
Ubiquitin-mediated proteolysis centers in HeLa cells: indication from studies of an inhibitor of the chymotrypsin-like activity of the proteasome. Eur J Cell Biol (1996) 1.42
Purification and specificity of a membrane-bound metalloendopeptidase from bovine pituitaries. Biochemistry (1981) 1.37
Comparison of the effect of calpain inhibitors on two extralysosomal proteinases: the multicatalytic proteinase complex and m-calpain. J Neurochem (1994) 1.37
Familial risks of congenital heart defect assessed in a population-based epidemiologic study. Am J Med Genet (1987) 1.34
Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B. Proc Natl Acad Sci U S A (1996) 1.32
gamma-Glutamyl dopa: a kidney-specific dopamine precursor. J Pharmacol Exp Ther (1978) 1.30
Inhibition of rabbit brain prolyl endopeptidase by n-benzyloxycarbonyl-prolyl-prolinal, a transition state aldehyde inhibitor. J Neurochem (1983) 1.22
Preparation and studies on the characterization of sheep brain glutamine synthetase. Biochemistry (1969) 1.20
Intermediates of the gamma-glutamyl cycle in mouse tissues. Influence of administration of amino acids on pyrrolidone carboxylate and gamma-glutamyl amino acids. Eur J Biochem (1975) 1.19
The anti-monoamine oxidase effects of furazolidone. J Pharmacol Exp Ther (1967) 1.12
Mechanism of action of plasma amine oxidase products released under anaerobic conditions. Biochemistry (1980) 1.10
Metabolism of gamma-glutamyl amino acids and peptides in mouse liver and kidney in vivo. Eur J Biochem (1976) 1.10
Amphetamine psychosis: behavioral and biochemical aspects. J Psychiatr Res (1974) 1.09
Clinical decision support system for point of care use--ontology-driven design and software implementation. Methods Inf Med (2009) 1.05
Determination of urinary 3-methoxy-4-hydroxyphenyl-ethylene glycol by gas-liquid chromatography and electron capture detection. Clin Chim Acta (1967) 1.04
Dentate granule neuron apoptosis and glia activation in murine hippocampus induced by trimethyltin exposure. Brain Res (2001) 1.03
Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors. Pharmacol Ther (2008) 1.03
Cardiac malformations in relatives of infants with hypoplastic left-heart syndrome. Am J Dis Child (1989) 1.02
Synthesis of ophthalmic acid in liver and kidney in vivo. Biochem J (1978) 1.00
Proteasome activator (PA28) subunits, alpha, beta and gamma (Ki antigen) in NT2 neuronal precursor cells and HeLa S3 cells. Eur J Cell Biol (1998) 0.99
Excretion of catecholamine catabolites by normal children. J Lab Clin Med (1968) 0.98
S 17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase. Biochem Biophys Res Commun (1999) 0.97
Phosphorylation of the multicatalytic proteinase complex from bovine pituitaries by a copurifying cAMP-dependent protein kinase. Arch Biochem Biophys (1990) 0.96
Purification and properties of a prolyl endopeptidase from rabbit brain. J Neurochem (1979) 0.96
Rat kidney glutamyl aminopeptidase (aminopeptidase A): molecular identity and cellular localization. Am J Physiol (1994) 0.95
Constitutive and protein kinase C-regulated secretory cleavage of Alzheimer's beta-amyloid precursor protein: different control of early and late events by the proteasome. J Neurochem (1997) 0.94
Morphological changes in the testis after long-term valproate treatment in male Wistar rats. Seizure (2001) 0.94
Serine and cysteine proteinase inhibitors prevent nitric oxide production by activated macrophages by interfering with transcription of the inducible NO synthase gene. Biochem Biophys Res Commun (1995) 0.92
Prolyl endopeptidase: inhibition in vivo by N-benzyloxycarbonyl-prolyl-prolinal. J Neurochem (1984) 0.91
Thyroid-stimulating hormone and insulin-like growth factor-1 synergize to elevate 1,2-diacylglycerol in rat thyroid cells. Stimulation of DNA synthesis via interaction between lipid and adenylyl cyclase signal transduction systems. J Clin Invest (1988) 0.91
Separation of cathepsin A-like enzyme and the proteasome: evidence that lactacystin/beta-lactone is not a specific inhibitor of the proteasome. Int J Biochem Cell Biol (2000) 0.90
An inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces arrest in G2-phase and metaphase in HeLa cells. Eur J Cell Biol (1996) 0.89
Protein kinase A phosphorylation of the proteasome: a contribution to the alpha-secretase pathway in human cells. J Neurochem (1996) 0.89
N-acyl-gamma-glutamyl derivatives of sulfamethoxazole as models of kidney-selective prodrugs. J Pharmacol Exp Ther (1980) 0.89
Differential inhibition of aminopeptidase A and aminopeptidase N by new beta-amino thiols. J Med Chem (1994) 0.89
The mitogen-activated protein kinase pathway inhibits ceramide-induced terminal differentiation of a human monoblastic leukemia cell line, U937. J Immunol (1998) 0.89
3,4-dichloroisocoumarin-induced activation of the degradation of beta-casein by the bovine pituitary multicatalytic proteinase complex. J Biol Chem (1992) 0.88
Telecommunication of images in the practice of diagnostic radiology. Radiology (1973) 0.88
Localization of immunoreactive glutamyl aminopeptidase in rat brain. II. Distribution and correlation with angiotensin II. Brain Res (1993) 0.88
Investigation of the active site of aminopeptidase A using a series of new thiol-containing inhibitors. J Med Chem (1994) 0.88
Comparing predictions made by a prediction model, clinical score, and physicians: pediatric asthma exacerbations in the emergency department. Appl Clin Inform (2013) 0.87
Modulation of endomorphin-2-induced analgesia by dipeptidyl peptidase IV. Brain Res (1999) 0.87
Subcellular distribution of prolyl endopeptidase and cation-sensitive neutral endopeptidase in rabbit brain. J Neurochem (1982) 0.87
Metabolism of vasoactive peptides by plasma and purified renal aminopeptidase M. Biochem Pharmacol (1990) 0.86
JLK isocoumarin inhibitors: selective gamma-secretase inhibitors that do not interfere with notch pathway in vitro or in vivo. J Neurosci Res (2003) 0.86
Proteasome contributes to the alpha-secretase pathway of amyloid precursor protein in human cells. J Neurochem (1997) 0.85
Aminoacylpyrrolidine-2-nitriles: potent and stable inhibitors of dipeptidyl-peptidase IV (CD 26). Arch Biochem Biophys (1995) 0.85
Pyroglutamyl peptidase II inhibition specifically increases recovery of TRH released from rat brain slices. Neuropeptides (1989) 0.85
Synergistic antitumor effects of a selective proteasome inhibitor and TNF in mice. Anticancer Res (2000) 0.85
Early prepubertal ontogeny of pulsatile gonadotropin-releasing hormone (GnRH) secretion: I. Inhibitory autofeedback control through prolyl endopeptidase degradation of GnRH. Endocrinology (1999) 0.84
Dopamine metabolites in human brain. Psychopharmacology (Berl) (1978) 0.84
A multicatalytic protease complex from pituitary that forms enkephalin and enkephalin containing peptides. Biochem Biophys Res Commun (1981) 0.84
Identification and partial purification of a cation-sensitive neutral endopeptidase from bovine pituitaries. Life Sci (1979) 0.83
Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. Psychopharmacol Commun (1975) 0.83
Determination of 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) in cerebrospinal fluid. Anal Biochem (1971) 0.83
Degradation of bradykinin by isolated neutral endopeptidases of brain and pituitary. Biochem Biophys Res Commun (1979) 0.82
The occurrence of free L-pyrrolidone carboxylic acid in body fluids and tissues. FEBS Lett (1973) 0.82
Studies on the subunit structure of ovine brain glutamine synthetase. Biochemistry (1969) 0.82
A novel chymotrypsin-like component of the multicatalytic proteinase complex optimally active at acidic pH. Arch Biochem Biophys (1995) 0.81
Delineation of a particulate thyrotropin-releasing hormone-degrading enzyme in rat brain by the use of specific inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase. J Neurochem (1986) 0.81
Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses. Basic Res Cardiol (2014) 0.81
Assessment of cerebrospinal fluid levels of dopamine metabolites by gas chromatography. Psychopharmacologia (1975) 0.80
Regulation of thyrotropin releasing hormone degrading enzymes in rat brain and pituitary by L-3,5,3'-triiodothyronine. J Neurochem (1989) 0.80
Evaluation of spermatological parameters used to predict the fertility of frozen bull semen. Acta Vet Scand (1993) 0.80
Chemical modification of the bovine pituitary multicatalytic proteinase complex by N-acetylimidazole. Reversible activation of casein hydrolysis. J Biol Chem (1991) 0.80
A quantitative assay for vanillylmandelic acid (VMA) by gas-liquid chromatography. Anal Biochem (1965) 0.79
Determination of pyrrolidone carboxylate and gamma-glutamyl amino acids by gas chromatography. Anal Biochem (1975) 0.79
Inhibition of prolyl oligopeptidase by Fmoc-aminoacylpyrrolidine-2-nitriles. J Neurochem (1996) 0.79
Mechanisms of regulation of agonist efficacy at the 5-HT(1A) receptor by phospholipid-derived signaling components. J Pharmacol Exp Ther (2001) 0.79
[Serotyping and drug resistance of Escherichia coli strains in healthy dogs and dogs with enteritis]. Berl Munch Tierarztl Wochenschr (1982) 0.79
Quantitation and regulation of pyroglutamyl peptidase II messenger RNA levels in rat tissues and GH3 cells. Neuroendocrinology (1998) 0.79
gamma-Glutamyl DOPA and gamma-glutamyl dopamine: effect on plasma glucose levels. Eur J Pharmacol (1979) 0.79
Enzymatic changes of the bovine pituitary multicatalytic proteinase complex, induced by magnesium ions. Arch Biochem Biophys (1992) 0.79
Factors influencing the success rate of artificial insemination with frozen semen in the dog. J Reprod Fertil Suppl (1989) 0.79
Signalling profile differences: paliperidone versus risperidone. Br J Pharmacol (2013) 0.79
Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine. J Pharmacol Exp Ther (1975) 0.78
Pyroglutamyl diazomethyl ketone: potent inhibitor of mammalian pyroglutamyl peptide hydrolase. Biochem Biophys Res Commun (1985) 0.78
Artificial insemination with frozen semen in dogs: a retrospective study. J Reprod Fertil Suppl (2001) 0.78
Changes in the structure and catalytic activities of the bovine pituitary multicatalytic proteinase complex following dialysis. J Biol Chem (1993) 0.78
Learning the preferences of physicians for the organization of result lists of medical evidence articles. Methods Inf Med (2014) 0.78
5-Hydroxytryptamine1-like receptors linked to increases in intracellular calcium concentration and inhibition of cyclic AMP accumulation in cultured vascular smooth muscle cells derived from bovine basilar artery. J Pharmacol Exp Ther (1993) 0.78
Thiethylperazine; clinical antipsychotic efficacy and correlation with potency in predictive systems. Arch Gen Psychiatry (1978) 0.78
Simultaneous determination of 3,4-dihydroxyphenylacetic acid and homovanillic acid in milligram amounts of rat striatal tissue by gas-liquid chromatography. Life Sci (1974) 0.78
Aminopeptidase A antiserum inhibits intracerebroventricular angiotensin II-induced dipsogenic and pressor responses. Brain Res (1997) 0.78
Derivatization and gas chromatographic determination of some biologically important acids in cerebrospinal fluid. Anal Biochem (1974) 0.78
Degradation of luteinizing hormone-releasing hormone (LHRH) by brain prolyl endopeptidase with release of des-glycinamide LHRH and glycinamide. Neurosci Lett (1979) 0.78
Localization of immunoreactive glutamyl aminopeptidase in rat brain. I. Association with cerebral microvessels. Brain Res (1993) 0.78
Insulin-like growth factor-I potentiates thyrotropin stimulation of adenylyl cyclase in FRTL-5 cells. Endocrinology (1989) 0.77
Specific inhibitors of pyroglutamyl peptidase I and prolyl endopeptidase do not change the in vitro release of TRH or its content in rodent brain. Neuropeptides (1987) 0.77